New product: Zejula (niraparib) capsules

Niraparib is licensed for use in patients with advanced epithelial (FIGO Stages III and IV) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response following platinum-based chemotherapy.

electronic Medicines compendium